Metacognitive functioning predicts positive and negative symptoms over 12 months in first episode psychosis

Journal of Psychiatric Research

Volumn 54, Issue 1, 2014, Pages 109-115

  McLeod, Hamish J ^a   Gumley, Andrew I ^a   MacBeth, Angus ^b,c   Schwannauer, Matthias ^d   Lysaker, Paul H ^e  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b ROYAL CORNHILL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

First episode psychosis; Metacognition; Negative symptoms

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DISTRESS SYNDROME; FEMALE; GENDER; HUMAN; MALE; MENTAL HEALTH; NEGATIVE SYNDROME; NEUROPSYCHIATRY; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PREDICTOR VARIABLE; PRIORITY JOURNAL; PSYCHOSIS; SYMPTOM; COGNITION DISORDERS; COMPLICATION; NEUROPSYCHOLOGICAL TEST; PREDICTIVE VALUE; PRODROMAL SYMPTOM; PROSPECTIVE STUDY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOTIC DISORDERS; SOCIAL BEHAVIOR; STATISTICAL MODEL; TIME; YOUNG ADULT;

ADULT; COGNITION DISORDERS; FEMALE; HUMANS; LINEAR MODELS; MALE; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PRODROMAL SYMPTOMS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SOCIAL BEHAVIOR; TIME FACTORS; YOUNG ADULT;

EID: 84899968627     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2014.03.018     Document Type: Article

References (60)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, Washington, DC. 4th ed, text rev.
2. Aleman A., Hijman R., de Haan E.H., Kahn R.S. Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry 1999, 156(9):1358-1366.
3. Barnes T.R., Paton C. Do antidepressants improve negative symptoms in schizophrenia?. Br Med J 2011, 342.
4. Beiser M., Erickson D., Fleming J.A., Iacono W.G. Establishing the onset of psychotic illness. Am J Psychiatry 1993, 150(9):1349-1354.
5. Bennouna-Greene M., Berna F., Conway M.A., Rathbone C.J., Vidailhet P., Danion J.-M. Self-images and related autobiographical memories in schizophrenia. Conscious Cogn 2012, 21(1):247-257.
6. Berna F., Bennouna-Greene M., Potheegadoo J., Verry P., Conway M.A., Danion J.-M. Impaired ability to give a meaning to personally significant events in patients with schizophrenia. Conscious Cogn 2011, 20(3):703-711.
7. Boonstra N., Klaassen R., Sytema S., Marshall M., De Haan L., Lex W., et al. Duration of untreated psychosis and negative symptoms - A systematic review and meta-analysis of individual patient data. Schizophrenia Res 2012 Dec 1, 142(1-3):12-19.
8. Bora E., Yucel M., Pantelis C. Theory of mind impairment in schizophrenia: meta-analysis. Schizophrenia Res 2009, 109(1-3):1-9.
9. Brune M. "Theory of mind" in schizophrenia: a review of the literature. Schizophr Bull 2005, 31(1):21-42.
10. Buchanan R.W. Persistent negative symptoms in schizophrenia: an overview. Schizophr Bull 2007, 33(4):1013-1022.
11. Cannon-Spoor H.E., Potkin S.G., Wyatt R.J. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 1982, 8(3):470.
12. Cartwright-Hatton S., Wells A. Beliefs about worry and intrusions: the Meta-Cognitions Questionnaire and its correlates. J Anxiety Disord 1997, 11(3):279-296.
13. Chang W.C., Tang J.Y.M., Hui C.L.M., Wong G.H.Y., Chan S.K.W., Lee E.H.M., et al. The relationship of early premorbid adjustment with negative symptoms and cognitive functions in first-episode schizophrenia: a prospective three-year follow-up study. Psychiatry Res 2013, 1-8.
14. Corcoran C.M., Kimhy D., Parrilla-Escobar M.A., Cressman V.L., Stanford A.D., Thompson J., et al. The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis. Psychol Med 2010, 41(02):251-261.
15. Dimaggio G., Vanheule S., Lysaker P.H., Carcione A., Nicolò G. Impaired self-reflection in psychiatric disorders among adults: a proposal for the existence of a network of semi independent functions. Conscious Cogn 2009 Sep 1, 18(3):653-664.
16. Elis O., Caponigro J.M., Kring A.M. Psychosocial treatments for negative symptoms in schizophrenia: current practices and future directions. Clin Psychol Rev 2013, 33(8):914-928.
17. Esterberg M., Compton M. Family history of psychosis negatively impacts age at onset, negative symptoms, and duration of untreated illness and psychosis in first-episode psychosis patients. Psychiatry Res 2012, 197(1-2):23-28.
18. Esterberg M.L., Trotman H.D., Holtzman C., Compton M.T., Walker E.F. The impact of a family history of psychosis on age-at-onset and positive and negative symptoms of schizophrenia: a meta-analysis. Schizophrenia Res 2010, 120(1-3):121-130.
19. Flavell J.H. Metacognition and cognitive monitoring. Am Psychol 1979, 34(10):906-911.
20. van der Gaag M., Hoffmann T., Remijsen M., Hijman R., De Haan L., van Meijel B., et al. The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model. Schizophrenia Res 2006, 85(1-3):280-287.
21. Grant P.M., Beck A.T. Defeatist beliefs as a mediator of cognitive impairment, negative symptoms, and functioning in schizophrenia. Schizophr Bull 2009, 35(4):798-806.
22. Grant P.M., Beck A.T. Asocial beliefs as predictors of asocial behavior in schizophrenia. Psychiatry Res 2010, 177(1):65-70.
23. Grant P.M., Huh G.A., Perivoliotis D., Stolar N.M., Beck A.T. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia. Arch Gen Psychiatry 2012, 69(2):121.
24. Halari R., Premkumar P., Farquharson L., Fannon D., Kuipers E., Kumari V. Rumination and negative symptoms in schizophrenia. J Nerv Ment Dis 2009, 197(9):703-706.
25. Hamm J.A., Renard S.B., Fogley R.L., Leonhardt B.L., Dimaggio G., Buck K.D., et al. Metacognition and social cognition in schizophrenia: stability and relationship to concurrent and prospective symptom assessments. J Clin Psychol 2012, 68(12):1303-1312.
26. Heinrichs R.W., Zakzanis K.K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998, 12(3):426-445.
27. Ho B.C., Nopoulos P., Flaum M., Arndt S., Andreasen N.C. Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. Am J Psychiatry 1998, 155(9):1196-1201.
28. Hunter R., Barry S. Negative symptoms and psychosocial functioning in schizophrenia: neglected but important targets for treatment. Eur Psychiatry 2012, 27(6):432-436.
29. Johnson D.P., Penn D.L., Fredrickson B.L., Kring A.M., Meyer P.S., Catalino L.I., et al. A pilot study of loving-kindness meditation for the negative symptoms of schizophrenia. Schizophrenia Res 2011, 129(2-3):137-140.
30. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13(2):261-276.
31. Kazdin A.E. Mediators and mechanisms of change in psychotherapy research. Annu Rev Clin Psychol 2007, 3(1):1-27.
32. Kendall T. Treating negative symptoms of schizophrenia. Br Med J 2012, 344. e664.
33. Klingberg S., Wolwer W., Engel C., Wittorf A., Herrlich J., Meisner C., et al. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical TONES study. Schizophr Bull 2011, 37(Suppl. 2):S98-S110.
34. Koren D., Seidman L.J., Goldsmith M., Harvey P.D. Real-world cognitive-and metacognitive-dysfunction in schizophrenia: a new approach for measuring (and remediating) more "Right Stuff.". Schizophr Bull 2006, 32(2):310-326.
35. Lyne J., O'Donoghue B., Owens E., Renwick L., Madigan K., Kinsella A., et al. Prevalence of item level negative symptoms in first episode psychosis diagnoses. Schizophrenia Res 2012, 135(1-3):128-133.
36. Lysaker P.H., Carcione A., Dimaggio G., Johannesen J.K., Nicolo G., Procacci M., et al. Metacognition amidst narratives of self and illness in schizophrenia: associations with neurocognition, symptoms, insight and quality of life. Acta Psychiatr Scand 2005, 112(1):64-71.
37. Lysaker P.H., Dimaggio G., Buck K.D., Carcione A., Nicolò G. Metacognition within narratives of schizophrenia: associations with multiple domains of neurocognition. Schizophrenia Res 2007, 93(1-3):278-287.
38. Lysaker P.H., Glynn S.M., Wilkniss S.M., Silverstein S.M. Psychotherapy and recovery from schizophrenia: a review of potential applications and need for future study. Psychol Serv 2010, 7(2):75-91.
39. Lysaker P.H., Gumley A., Luedtke B., Buck K.D., Ringer J.M., Olesek K., et al. Social cognition and metacognition in schizophrenia: evidence of their independence and linkage with outcomes. Acta Psychiatr Scand 2013, 127(3):239-247.
40. Lysaker P.H., Ringer J.M., Buck K.D., Grant M., Olesek K., Leudtke B.L., et al. Metacognitive and social cognition deficits in patients with significant psychiatric and medical adversity. J Nerv Ment Dis 2012, 200(2):130-134.
41. Lysaker P.H., Vohs J.L., Ballard R., Fogley R., Salvatore G., Popolo R., et al. Metacognition, self-reflection and recovery in schizophrenia. Future Neurol 2013, 8(1):103-115.
42. Lysaker P.H., Warman D.M., Dimaggio G., Procacci M., LaRocco V.A., Clark L.K., et al. Metacognition in schizophrenia. J Nerv Ment Dis 2008, 196(5):384-389.
43. Macbeth A., Gumley A. Premorbid adjustment, symptom development and quality of life in first episode psychosis: a systematic review and critical reappraisal. Acta Psychiatr Scand 2007, 117(2):85-99.
44. MacBeth A., Gumley A., Schwannauer M., Carcione A., Fisher R., McLeod H.J., et al. Metacognition, symptoms and premorbid functioning in a First Episode Psychosis sample. Compr Psychiatry 2014, 55(2):268-273.
45. Main M., Goldwyn R., Hesse E. Adult attachment scoring and classification systems 2002, University of California. 7th ed.
46. Milev P., Ho B.C., Arndt S., Andreasen N.C. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry 2005, 162(3):495-506.
47. Mishara A.L., Lysaker P.H., Schwartz M.A. Self-disturbances in schizophrenia: history, phenomenology, and relevant findings from research on metacognition. Schizophr Bull 2013, 10.1093/schbul/sbt169.
48. Moritz S., Vitzthum F., Randjbar S., Veckenstedt R., Woodward T.S. Detecting and defusing cognitive traps: metacognitive intervention in schizophrenia. Curr Opin Psychiatry 2010, 23(6):561-569.
49. Morrison A.P., Wells A. A comparison of metacognitions in patients with hallucinations, delusions, panic disorder, and non-patient controls. Behav Res Ther 2003, 41(2):251-256.
50. Murphy B.P., Chung Y.-C., Park T.-W., McGorry P.D. Pharmacological treatment of primary negative symptoms in schizophrenia: a systematic review. Schizophrenia Res 2006, 88(1-3):5-25.
51. Nicolo G., Dimaggio G., Popolo R., Carcione A., Procacci M., Hamm J., et al. Associations of metacognition with symptoms, insight, and neurocognition in clinically stable outpatients with schizophrenia. J Nerv Ment Dis 2012, 200(7):644-647.
52. Pickup G.J., Frith C.D. Theory of mind impairments in schizophrenia: symptomatology, severity and specificity. Psychol Med 2001, 31(02):207-220.
53. Piskulic D., Addington J., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Heinssen R., et al. Negative symptoms in individuals at clinical high risk of psychosis. Psychiatry Res 2012, 196(2-3):220-224.
54. Provencher H.L., Mueser K.T. Positive and negative symptom behaviors and caregiver burden in the relatives of persons with schizophrenia. Schizophrenia Res 1997, 26(1):71-80.
55. Rector N.A., Beck A.T., Stolar N. The negative symptoms of schizophrenia: a cognitive perspective. Can J Psychiatry 2005, 50(5):247-257.
56. Röhricht F., Priebe S. Effect of body-oriented psychological therapy on negative symptoms in schizophrenia: a randomized controlled trial. Psychol Med 2006, 36(05):669-678.
57. Salvatore G., Dimaggio G., Lysaker P.H. An intersubjective perspective on negative symptoms of schizophrenia: implications of simulation theory. Cogn Neuropsychiatry 2007, 12(2):144-164.
58. Semerari A., Carcione A., Dimaggio G., Falcone M., Nicol G., Procacci M., et al. How to evaluate metacognitive functioning in psychotherapy? The metacognition assessment scale and its applications. Clin Psychol Psychotherapy 2003, 10(4):238-261.
59. Skeate A., Jackson C., Birchwood M., Jones A. Duration of untreated psychosis and pathways to care in first-episode psychosis investigation of help-seeking behaviour in primary care. Br J Psychiatry 2002, 181(43):s73-s77.
60. Staring A.B.P., ter Huurne M.-A.B., van der Gaag M. Cognitive Behavioral Therapy for negative symptoms (CBT-n) in psychotic disorders: a pilot study. J Behav Ther Exp Psychiatry 2013, 44(3):300-306.